iCAD to release new MRI product suite

TriMed Staff | July 20, 2010 | Health Exec | Precision Medicine

Image analysis technology provider iCAD has combined several of its offerings to create a new MRI product suite for cancer detection, staging, localization, treatment planning and serial monitoring of the breast, prostate and other organs.

The Nashua, N.H.-based company said the MRI product suite will combine its current products: SpectraLook, VividLook, OmniLook and VersaVue Enterprise. The technology will offer integrated 3D and 4D displays; colorized displays on any underlying MR sequence; creation of customized hanging protocols and creation of 2D, 3D, MIP (Maximum Intensity Projection) and MPR (Multi-Planar Reformat) images from any image in the viewport; and advanced image manipulation icons in each viewport.

The technology will be made available for purchase in August, said iCAD.

TriMed Staff

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

iCAD to release new MRI product suite

Related Content

Around the web